Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: Sir Auric Goldfinger who wrote (707)	11/16/1998 8:28:00 AM
From: TRIIBoy	Read Replies (1) \| Respond to of 19428

As I thought, VTCH has not released its 10-Q on time...again... I'm glad it is out of gas, but when is this fraud going to trade where it should...$5 to $6 per share??

To: Sir Auric Goldfinger who wrote (707)	11/16/1998 11:34:00 PM
From: Jim Roof	Read Replies (1) \| Respond to of 19428

BTIM is a fraud A fraud with the backing of Abbott Labs and the quantitative success of completed Phase III Clinical Trials. The biggest fraud surrounding BTIM has been the deliberate distortions and outright lies by Manuel Asensio. Biotime actually has a product and that product has been demonstrated to the medical community and has been awarded patents. I will give you the fact that some analysts have been way overboard in their enthusiasm but to state outright that this company is a 'fraud' implies that one of just a few things must be true: 1) The company pretends to have a product that they actually do not possess (Asensio's worn out 'blood substitute' line is old news and anyone with an IQ just over their shoe size could read BTIM's prospectus to find out what Hextend is all about) 2) The data from the trials was inaccurately reported 3) The management has made statements which caused an unwarranted appreciation in the stock price and then dumped their shares at highly inflated levels 4) The company has filed inaccurate and misleading corporate douments and SEC filings To the best of my knowledge Hextend is a real product, the Phase III trials were conducted at respected and fully accredited facilities and were performed in a scientifically correct methodology, while BTIM's price was skyrocketing just over a year ago there was no insider selling (in fact, when it fell later under Asensio's media pressure insiders added to their positions), and finally, no one has yet claimed that Biotime is filing bad numbers. Wherein lies the fraud? Jim (long at 9)